LRMR Operating Cash Flow (Statement)
Larimar Therapeutics Inc · Operating Cash Flow (Statement)
LRMR Operating Cash Flow (Statement)
Latest reported-$155.92Mperiod ending
LRMR TTM Cash from Operations (-$59.55M → -$155.92M)
TTM operating cash flow (statement)
High-resolution chart · PNG
LRMR operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -155,924,000 | |
| -131,275,000 | |
| -113,201,000 | |
| -96,489,000 | |
| -92,282,000 | |
| -86,889,000 | |
| -70,760,000 | |
| -58,288,000 | |
| -42,942,000 | |
| -36,319,000 | |
| -33,459,000 | |
| -30,788,000 | |
| -27,466,000 | |
| -27,587,000 | |
| -27,569,000 | |
| -28,815,000 | |
| -35,136,000 | |
| -38,432,000 | |
| -42,105,000 | |
| -44,044,000 | |
| -43,067,000 | |
| -44,484,000 | |
| -42,199,000 | |
| -40,253,000 | |
| -34,854,000 | |
| -25,805,000 | |
| -22,699,000 | |
| -53,010,000 | |
| -60,263,000 | |
| -70,378,000 | |
| -52,884,000 | |
| -26,341,000 | |
| 4,496,000 | |
| 0 | |
| -60,146,000 | |
| -59,554,000 |